Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pilot Phase Of Operation Warp Speed For Rare Diseases Beginning Soon

Sep 21 2023

• By Derrick Gingery

Operation Warp Speed and flag — Concepts used for development of COVID-19 vaccines could be implemented to speed development of gene therapies for rare diseases. • Source: Shutterstock

Related Content

PDUFA VII Commitment Letter Outlines Real-Time Review Expansion, Hiring Goals

Aug 23 2021

Operation Warp Speed For Rare Diseases? US FDA Is Considering Pilot Programs

Jun 29 2022

FDA Gene Therapy Office Chief Prefers Flexibility With Accelerated Approval Confirmatory Trials

Sep 24 2023

US FDA’s Gene Therapy Office Director Nicole Verdun Must Fill Other Roles As Well

Aug 18 2023

US FDA Holds First Hybrid Meeting With Industry

Mar 29 2023

FDA's Marks Sees 'Two Or Three Year Window' To Transform Gene Therapy Environment

Apr 11 2023

US FDA Hiring Data: CBER Exceeds CDER In Progress Toward Goals

Jul 21 2023

How Can FDA Advance Cell Therapy R&D? Issue Guidance in ‘Real Time,’ Encourage Collaboration With Industry, CBER’s Marks Says

Jun 21 2023

Additional Topics

United States Gene Therapy Rare Diseases Regulation Research & Development BioPharmaceutical

More from Cell & Gene Therapies

More from Advanced Technologies

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window